230 related articles for article (PubMed ID: 10395329)
1. Cancer therapy using a self-replicating RNA vaccine.
Ying H; Zaks TZ; Wang RF; Irvine KR; Kammula US; Marincola FM; Leitner WW; Restifo NP
Nat Med; 1999 Jul; 5(7):823-7. PubMed ID: 10395329
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA.
Yamanaka R; Zullo SA; Tanaka R; Blaese M; Xanthopoulos KG
J Neurosurg; 2001 Mar; 94(3):474-81. PubMed ID: 11235953
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene.
Cheng WF; Hung CF; Chai CY; Hsu KF; He L; Rice CM; Ling M; Wu TC
J Immunol; 2001 May; 166(10):6218-26. PubMed ID: 11342644
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen.
Cheng WF; Hung CH; Chai CY; Hsu KF; He L; Ling M; Wu TC
J Virol; 2001 Mar; 75(5):2368-76. PubMed ID: 11160740
[TBL] [Abstract][Full Text] [Related]
5. DNA and RNA-based vaccines: principles, progress and prospects.
Leitner WW; Ying H; Restifo NP
Vaccine; 1999 Dec; 18(9-10):765-77. PubMed ID: 10580187
[TBL] [Abstract][Full Text] [Related]
6. Induction of a therapeutic antitumor immunological response by intratumoral injection of genetically engineered Semliki Forest virus to produce interleukin-12.
Yamanaka R; Zullo SA; Tanaka R; Ramsey J; Blaese M; Xanthopoulos KG
Neurosurg Focus; 2000 Dec; 9(6):e7. PubMed ID: 16817690
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments.
Cheng WF; Hung CF; Hsu KF; Chai CY; He L; Ling M; Slater LA; Roden RB; Wu TC
Hum Gene Ther; 2001 Feb; 12(3):235-52. PubMed ID: 11177561
[TBL] [Abstract][Full Text] [Related]
8. Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12.
Yamanaka R; Zullo SA; Ramsey J; Yajima N; Tsuchiya N; Tanaka R; Blaese M; Xanthopoulos KG
J Neurosurg; 2002 Sep; 97(3):611-8. PubMed ID: 12296646
[TBL] [Abstract][Full Text] [Related]
9. Intra-pinna anti-tumor vaccination with self-replicating infectious RNA or with DNA encoding a model tumor antigen and a cytokine.
Schirmacher V; Förg P; Dalemans W; Chlichlia K; Zeng Y; Fournier P; von Hoegen P
Gene Ther; 2000 Jul; 7(13):1137-47. PubMed ID: 10918481
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors.
Leitner WW; Ying H; Driver DA; Dubensky TW; Restifo NP
Cancer Res; 2000 Jan; 60(1):51-5. PubMed ID: 10646851
[TBL] [Abstract][Full Text] [Related]
11. Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.
Vidalin O; Fournillier A; Renard N; Chen M; Depla E; Boucreux D; Brinster C; Baumert T; Nakano I; Fukuda Y; Liljeström P; Trépo C; Inchauspé G
Virology; 2000 Oct; 276(2):259-70. PubMed ID: 11040118
[TBL] [Abstract][Full Text] [Related]
12. Self-replicating Semliki Forest virus RNA as recombinant vaccine.
Zhou X; Berglund P; Rhodes G; Parker SE; Jondal M; Liljeström P
Vaccine; 1994 Dec; 12(16):1510-4. PubMed ID: 7879415
[TBL] [Abstract][Full Text] [Related]
13. Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity.
Anraku I; Harvey TJ; Linedale R; Gardner J; Harrich D; Suhrbier A; Khromykh AA
J Virol; 2002 Apr; 76(8):3791-9. PubMed ID: 11907219
[TBL] [Abstract][Full Text] [Related]
14. Comparative immunization study using RNA and DNA constructs encoding a part of the Plasmodium falciparum antigen Pf332.
Andersson C; Vasconcelos NM; Sievertzon M; Haddad D; Liljeqvist S; Berglund P; Liljeström P; Ahlborg N; Ståhl S; Berzins K
Scand J Immunol; 2001; 54(1-2):117-24. PubMed ID: 11439157
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of Semliki Forest virus based self-amplifying RNA expressing Indian HIV-1C genes in mice.
Ajbani SP; Velhal SM; Kadam RB; Patel VV; Bandivdekar AH
Int J Biol Macromol; 2015 Nov; 81():794-802. PubMed ID: 26361864
[TBL] [Abstract][Full Text] [Related]
16. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
[TBL] [Abstract][Full Text] [Related]
17. Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.
Zhou X; Berglund P; Zhao H; Liljeström P; Jondal M
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):3009-13. PubMed ID: 7708765
[TBL] [Abstract][Full Text] [Related]
18. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
[TBL] [Abstract][Full Text] [Related]
19. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
20. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways.
Leitner WW; Hwang LN; deVeer MJ; Zhou A; Silverman RH; Williams BR; Dubensky TW; Ying H; Restifo NP
Nat Med; 2003 Jan; 9(1):33-9. PubMed ID: 12496961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
